Position in OGI
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,485
-$673 QoQ
Shares Held
1,456
-9.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 69 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $6,951,552 across 44 Drug Manufacturers - Specialty & Generic names. OGI ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
143,876 | $4,874,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,544 | $836,585 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,008 | $506,968 | |
| 4 | ZTS |
Zoetis Inc.
|
2,994 | $215,148 | |
| 5 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 6 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
447 | $49,590 | |
| 8 | VTRS |
Viatris Inc
|
2,398 | $38,080 |
All Filings in OGI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,485 | 1,456 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,158 | 1,611 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,706 | 1,611 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $525 | 259 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $349 | 259 | Shares | Sole | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||